Ischemic
14
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
1 terminated out of 14 trials
85.7%
-0.8% vs benchmark
21%
3 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
Passive Limb Movement Study
Monitoring of NOAC Therapy: Standardizing Reference Intervals
Cognitive Multi-sensory Rehabilitation on Upper Limb Function and Fatigue in Stroke
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
REal-World Analyses of Stroke - Thrombus Occlusion REtrieval
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Evaluation of the Impact of the Repositioning Schedule Adapted to the Risk of Pressure Ulcer of Patients in Intensive Care Unit
Effects of Cognitive Exercises With Sensory Motor Relearning Program on Upper Limb Function in Sub-Acute Stroke Patients
Analysis of the Impact of the Fragility of the Over 70 Years of TIAprognosis
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Regional Strategy for Transfer for Mechanical Thrombectomy
ROSSETTI: Registry of Combined vs Single Thrombectomy Techniques
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke